Abstract:Background TBX1 (T-box transcription factor 1) is a major candidate gene that likely contributes to the etiology of velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS). Although the haploinsufficiency of TBX1 in both mice and humans results in congenital cardiac malformations, little has been elucidated about its upstream regulation. We aimed to explore the transcriptional regulation and dysregulation of TBX1 . Methods Different TBX1 promoter reporters were constructed. Luciferase assays and electrophoretic mobility shift assays (EMSAs) were used to identify a cis -regulatory element within the TBX1 promoter region and its trans -acting factor. The expression of proteins was identified by immunohistochemistry and immunofluorescence. Variants in the cis -regulatory element were screened in conotruncal defect (CTD) patients. In vitro functional assays were performed to show the effects of the variants found in CTD patients on the transactivation of TBX1 . Results We identified a cis -regulatory element within intron 1 of TBX1 that was found to be responsive to GATA6 (GATA binding protein 6), a transcription factor crucial for cardiogenesis. The expression patterns of GATA6 and TBX1 overlapped in the pharyngeal arches of human embryos. Transfection experiments and EMSA indicated that GATA6 could activate the transcription of TBX1 by directly binding with its GATA cis -regulatory element in vitro. Furthermore, sequencing analyses of 195 sporadic CTD patients without the 22q11.2 deletion or duplication identified 3 variants (NC_000022.11:g.19756832C > G, NC_000022.11:g.19756845C > T, and NC_000022.11:g. 19756902G > T) in the non-coding cis -regulatory element of TBX1 . Luciferase assays showed that all 3 variants led to reduced transcription of TBX1 when incubated with GATA6. Conclusions Our findings showed that TBX1 might be a direct transcriptional target of GATA6, and variants in the non-coding cis -regulatory element of TBX1 disrupted GATA6-mediated transactivation.

Increased TBX6 gene dosages induce congenital cervical vertebral malformations in humans and mice.

Increased<i>TBX6</i>gene dosages induce congenital cervical vertebral malformations in humans and mice

TBX6 Compound Inheritance Leads to Congenital Vertebral Malformations in Humans and Mice

Progress and Perspective of TBX6 Gene in Congenital Vertebral Malformations

A Mutation in TBXT Causes Congenital Vertebral Malformations in Humans and Mice.

Mutant <i>B3GALT6</i> in a Multiplex Family: A Dominant Variant Co-Segregated With Moderate Malformations

TBX6 Missense Variants Expand the Mutational Spectrum in a Non-Mendelian Inheritance Disease.

TBX6-associated congenital scoliosis (TACS) as a clinically distinguishable subtype of congenital scoliosis: further evidence supporting the compound inheritance and TBX6 gene dosage model

Human and mouse studies establish TBX6 in Mendelian CAKUT and as a potential driver of kidney defects associated with the 16p11.2 microdeletion syndrome

Unraveling the Genetic Architecture of Congenital Vertebral Malformation with Reference to the Developing Spine

TBX6 null variants and a common hypomorphic allele in congenital scoliosis.

TBX1 Loss-of-function Mutation Contributes to Congenital Conotruncal Defects

Concurrent of compound heterozygous variant of a novel in-frame deletion and the common hypomorphic haplotype in TBX6 and inherited 17q12 microdeletion in a fetus

Variants in a Cis-Regulatory Element of TBX1 in Conotruncal Heart Defect Patients Impair GATA6-mediated Transactivation.

Genetic variants of <i>TBX6</i> and <i>TBXT</i> identified in patients with congenital scoliosis in Southern China

Core planar cell polarity genes VANGL1 and VANGL2 in predisposition to congenital vertebral malformations

TBX6 as a cause of a combined skeletal‐kidney dysplasia syndrome

Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study

Noncoding Rare Variants of TBX6 in Congenital Anomalies of the Kidney and Urinary Tract.

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block